Symrise releases first quarter results: up 7.5% with organic growth

By Lucy Whitehouse

- Last updated on GMT

Symrise releases first quarter results: up 7.5% with organic growth
Group sales up by 1.5 % to € 776.9 million, including portfolio and exchange rate effects, the global fragrance and ingredients player says.

It saw an EBITDA margin with 20.1 % within target corridor, and states that shortage of some raw materials did not impact on delivery capability.

Symrise states that its guidance for 2018 and medium-term targets through to 2020 are affirmed by these results.

Fragrances and Cosmetic Ingredients out in front

According to Symrise’s report which accompanies its latest results, which cover the period Jan - Mar 2018, its Scent & Care division’s good sales growth owes a lot to its fragrances and cosmetics ingredients.

Scent & Care posted a 6.9 % organic sales increase in the first quarter, says the company.

Considering the negative currency effects and the portfolio effect from the Citratus acquisition, sales in reporting currency amounted to € 331.8 million, and thus were slightly lower than year-on-year.

Aroma Molecules in focus

The Aroma Molecules division delivered the strongest growth, with organic double-digit percentage increases, in particular in applications for fragrance ingredients.

The Cosmetic Ingredients division achieved strong organic growth in the high single-digit percentage range, showing particularly expansive developments in the Asia/Pacific and Latin America regions.

Beauty Care driving

The Fragrance division reported a moderate organic increase in sales, especially driven by the Beauty Care and Home Care business units.

Beauty Care, which develops and markets body and facial care applications, realized strong organic growth especially in the Asia/Pacific and Latin America regions.

In the Home Care business unit, healthy increases were seen in the Asia/Pacific, EAME and Latin America regions, mainly through new business with regional customers.

The Fine Fragrances business unit achieved a double-digit growth rate in Latin America as a result of higher demand from regional and local customers.

Negative currency effects

The EBITDA for the Scent & Care segment in the first quarter amounted to € 64.8 million (Q1 2017: € 71.9 million).

The year-on-year decrease reflects negative currency effects, higher prices for raw materials and the one-off gain from the sale of the Pinova industrial activities.

The EBITDA margin was 19.5 % (Q1 2017: 21.6 %).

Related news

Show more

Related products

show more

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us

Products

View more

Podcast

Beauty 4.0 Podcast